Next Article in Journal
Membrane Permeability and Aqueous Stability Study of Linear and Cyclic Diarylheptanoids from Corylus maxima
Next Article in Special Issue
Molecular and Nano-Structural Optimization of Nanoparticulate Mn2+-Hexarhenium Cluster Complexes for Optimal Balance of High T1- and T2-Weighted Contrast Ability with Low Hemoagglutination and Cytotoxicity
Previous Article in Journal
Integrating In Vitro and In Silico Analysis of a Cationic Antimicrobial Peptide Interaction with Model Membranes of Colistin-Resistant Pseudomonas aeruginosa Strains
Previous Article in Special Issue
Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies

by
Mariana P. Nucci
1,2,†,
Javier B. Mamani
1,†,
Fernando A. Oliveira
1,
Igor S. Filgueiras
1,
Arielly H. Alves
1,
Matheus H. Theinel
1,
Luiz D. Rodrigues
3,
Luciana Marti
1 and
Lionel F. Gamarra
1,*
1
Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil
2
LIM44—Hospital das Clínicas da Faculdade Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil
3
Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo, São Paulo 05508-270, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2022, 14(6), 1249; https://doi.org/10.3390/pharmaceutics14061249
Submission received: 22 May 2022 / Revised: 6 June 2022 / Accepted: 9 June 2022 / Published: 12 June 2022
(This article belongs to the Special Issue Magnetic Nanoparticles for Therapy and Diagnosis in Nanomedicine)

Abstract

Considering there are several difficulties and limitations in labeling stem cells using multifunctional nanoparticles (MFNP), the purpose of this study was to determine the optimal conditions for labeling human bone marrow mesenchymal stem cells (hBM-MSC), aiming to monitor these cells in vivo. Thus, this study provides information on hBM-MSC direct labeling using multimodal nanoparticles in terms of concentration, magnetic field, and period of incubation while maintaining these cells’ viability and the homing ability for in vivo experiments. The cell labeling process was assessed using 10, 30, and 50 µg Fe/mL of MFNP, with periods of incubation ranging from 4 to 24 h, with or without a magnetic field, using optical microscopy, near-infrared fluorescence (NIRF), and inductively coupled plasma mass spectrometry (ICP-MS). After the determination of optimal labeling conditions, these cells were applied in vivo 24 h after stroke induction, intending to evaluate cell homing and improve NIRF signal detection. In the presence of a magnetic field and utilizing the maximal concentration of MFNP during cell labeling, the iron load assessed by NIRF and ICP-MS was four times higher than what was achieved before. In addition, considering cell viability higher than 98%, the recommended incubation time was 9 h, which corresponded to a 25.4 pg Fe/cell iron load (86% of the iron load internalized in 24 h). The optimization of cellular labeling for application in the in vivo study promoted an increase in the NIRF signal by 215% at 1 h and 201% at 7 h due to the use of a magnetized field during the cellular labeling process. In the case of BLI, the signal does not depend on cell labeling showing no significant differences between unlabeled or labeled cells (with or without a magnetic field). Therefore, the in vitro cellular optimized labeling process using magnetic fields resulted in a shorter period of incubation with efficient iron load internalization using higher MFNP concentration (50 μgFe/mL), leading to significant improvement in cell detection by NIRF technique without compromising cellular viability in the stroke model.
Keywords: multimodal nanoparticle; labeling; magnetic field; incubation time; mesenchymal stem cell; cell therapy; stroke; near-infrared fluorescence image; bioluminescence; ICP-MS multimodal nanoparticle; labeling; magnetic field; incubation time; mesenchymal stem cell; cell therapy; stroke; near-infrared fluorescence image; bioluminescence; ICP-MS

Share and Cite

MDPI and ACS Style

Nucci, M.P.; Mamani, J.B.; Oliveira, F.A.; Filgueiras, I.S.; Alves, A.H.; Theinel, M.H.; Rodrigues, L.D.; Marti, L.; Gamarra, L.F. Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies. Pharmaceutics 2022, 14, 1249. https://doi.org/10.3390/pharmaceutics14061249

AMA Style

Nucci MP, Mamani JB, Oliveira FA, Filgueiras IS, Alves AH, Theinel MH, Rodrigues LD, Marti L, Gamarra LF. Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies. Pharmaceutics. 2022; 14(6):1249. https://doi.org/10.3390/pharmaceutics14061249

Chicago/Turabian Style

Nucci, Mariana P., Javier B. Mamani, Fernando A. Oliveira, Igor S. Filgueiras, Arielly H. Alves, Matheus H. Theinel, Luiz D. Rodrigues, Luciana Marti, and Lionel F. Gamarra. 2022. "Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies" Pharmaceutics 14, no. 6: 1249. https://doi.org/10.3390/pharmaceutics14061249

APA Style

Nucci, M. P., Mamani, J. B., Oliveira, F. A., Filgueiras, I. S., Alves, A. H., Theinel, M. H., Rodrigues, L. D., Marti, L., & Gamarra, L. F. (2022). Optimization of Multimodal Nanoparticles Internalization Process in Mesenchymal Stem Cells for Cell Therapy Studies. Pharmaceutics, 14(6), 1249. https://doi.org/10.3390/pharmaceutics14061249

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop